Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

All content curated by

Shyoko Honiden MD, MSc

Virginia Brady MD

Geoffrey Connors MD, FACP

See All Experts

featured

Published in Respiratory Medicine

Journal Scan / Research · July 28, 2021

Effects of Tezepelumab in Patients With Moderate to Severe Uncontrolled Asthma

The Lancet Respiratory Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Morgan Soffler MD

The Lancet Respiratory Medicine

Effect of Tezepelumab on Airway Inflammatory Cells, Remodelling, and Hyperresponsiveness in Patients With Moderate-to-Severe Uncontrolled Asthma (CASCADE): A Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial

Lancet Respir Med 2021 Jul 09;[EPub Ahead of Print], S Diver, L Khalfaoui, C Emson, SE Wenzel, A Menzies-Gow, ME Wechsler, J Johnston, N Molfino, JR Parnes, A Megally, G Colice, CE Brightling

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Effects of Tezepelumab in Patients With Moderate to Severe Uncontrolled Asthma

Additional Info

Effect of Tezepelumab on Airway Inflammatory Cells, Remodelling, and Hyperresponsiveness in Patients With Moderate-to-Severe Uncontrolled Asthma (CASCADE): A Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial

Further Reading

Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD

Prevalence of Critical Errors and Insufficient Peak Inspiratory Flow in Patients Hospitalized With COPD

Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis

Role of Biomarker Testing in Guiding Precision Medicine for Patients With Non–Small Cell Lung Cancer

Association Between Naloxone and Clinical Outcomes Among Patients With Out-of-Hospital Cardiac Arrest

Identification, Prevention, and Management of Complications Caused by Devices in the ICU

Safety and Tolerability of Bexotegrast in the Treatment of Patients With IPF

Impact of Age, Frailty, and Multimorbidity on the Effect of ICU Interventions

Deep Learning–Based Segmentation of CT Scans Predicts Disease Progression and Mortality in Patients With IPF

Association Between Exacerbation History and Risk of Myocardial Infarction and Pulmonary Embolism in COPD

Effect of Metagenomic Next-Generation Sequencing on Clinical Outcomes in Patients With Severe Community-Acquired Pneumonia in ICU

Recently Updated